We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

186 hedge funds and large institutions have $466M invested in PDL BioPharma, Inc. in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 44 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 13

45% more capital invested

Capital invested by funds: $321M → $466M (+$145M)

43% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 44

9% more funds holding

Funds holding: 171 → 186 (+15)

37% less call options, than puts

Call options by funds: $450K | Put options by funds: $717K

Holders
186
Holders Change
+15
Holders Change %
+8.77%
% of All Funds
4.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
63
Reduced
44
Closed
13
Calls
$450K
Puts
$717K
Net Calls
-$267K
Net Calls Change
-$555K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$8.55M
2
Morgan Stanley
Morgan Stanley
New York
+$6.49M
3
State Street
State Street
Massachusetts
+$5.81M
4
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$3.96M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.56M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$9.56M
2
Bank of America
Bank of America
North Carolina
-$4.6M
3
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$3.61M
4
BlackRock
BlackRock
New York
-$2.18M
5
Deutsche Bank
Deutsche Bank
Germany
-$2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Public Employees Retirement Association of Colorado
101
Public Employees Retirement Association of Colorado
Colorado
$193K – – –
CAM
102
ClariVest Asset Management
California
$193K +$6.1K +2,195 +4%
BNP Paribas Financial Markets
103
BNP Paribas Financial Markets
France
$182K +$87.4K +31,418 +142%
Jacobs Levy Equity Management
104
Jacobs Levy Equity Management
New Jersey
$180K +$147K +53,000 New
BCM
105
Bridgeway Capital Management
Texas
$170K – – –
CSS
106
Cubist Systematic Strategies
Connecticut
$166K +$53.2K +19,144 +64%
VRS
107
Virginia Retirement Systems
Virginia
$161K -$13.6K -4,900 -9%
Legal & General Group
108
Legal & General Group
United Kingdom
$151K +$12.1K +4,336 +11%
IFS
109
Ifrah Financial Services
Arkansas
$148K +$870 +313 +0.7%
VF
110
Virtu Financial
New York
$147K +$121K +43,434 New
FA
111
Fortis Advisors
Pennsylvania
$146K +$120K +43,032 New
MCM
112
Matarin Capital Management
New York
$143K +$117K +42,170 New
Cambridge Investment Research Advisors
113
Cambridge Investment Research Advisors
Iowa
$139K -$261 -94 -0.2%
Creative Planning
114
Creative Planning
Kansas
$131K +$7.42K +2,670 +7%
DTL
115
Dynamic Technology Lab
Singapore
$131K +$107K +38,458 New
BCM
116
Bayesian Capital Management
New York
$122K +$99.8K +35,875 New
WA
117
WealthTrust Axiom
Pennsylvania
$111K +$8.34K +3,000 +10%
Barclays
118
Barclays
United Kingdom
$107K +$46.8K +16,831 +115%
PP
119
Paloma Partners
Connecticut
$106K +$709 +255 +0.8%
TAM
120
Tocqueville Asset Management
New York
$98K +$80.2K +28,853 New
SG Americas Securities
121
SG Americas Securities
New York
$97K +$79.2K +28,472 New
Simplex Trading
122
Simplex Trading
Illinois
$92K +$75.8K +27,254 New
QI
123
Quotient Investors
New York
$88K +$72.3K +26,000 New
BCM
124
BlueCrest Capital Management
Jersey
$86K +$40K +14,391 +130%
Barrow, Hanley, Mewhinney & Strauss
125
Barrow, Hanley, Mewhinney & Strauss
Texas
$79K -$6.08K -2,186 -9%
3 4
5
6 7

PDLI Hedge Fund Activity: Q3 2017 in Review

186 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q3 2017, worth a combined $466M — up 45% from $321M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PDLI positions and 13 closed out — a net gain of 18 holders — while 63 added to existing stakes and 44 trimmed.

The largest buyer was Millennium Management, adding an estimated $8.55M. The largest seller was Citadel Advisors, cutting an estimated $9.56M.

  • 186 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q3 2017, up from 171 in Q2 2017.
  • Funds reported $466M of PDL BioPharma, Inc. stock for Q3 2017, up 45% quarter-over-quarter.
  • 31 funds opened new PDL BioPharma, Inc. positions in Q3 2017 and 13 closed out, a net change of +18 holders.
  • The largest PDL BioPharma, Inc. buyer in Q3 2017 was Millennium Management, an estimated $8.55M added.
  • The largest PDL BioPharma, Inc. seller in Q3 2017 was Citadel Advisors, an estimated $9.56M sold.

Based on aggregated 13F filings for Q3 2017.